HomeNewsCosta RicaAstraZeneca vaccine benefits ‘outweigh the risks,’ EMA says

AstraZeneca vaccine benefits ‘outweigh the risks,’ EMA says

Costa Rica on Wednesday will receive its first doses of the AstraZeneca coronavirus vaccine. Administration of this formula has been suspended by several countries over concerns about blood clots.

Daniel Salas, Health Minister, has said Costa Rica plans to apply the AstraZeneca vaccine but will monitor international studies pertaining to a possible link between the shot and adverse health issues.

“We are giving time for the competent agencies to do the respective investigations based on solid information, which allows us to better evaluate the behavior to follow,” Salas said in mid-March.

“There is currently no scientifically proven link between the application of the vaccine and the appearance of blood clots; that is under investigation.”

Costa Rica approved the AstraZeneca vaccine in February based on the endorsement of the European Medicines Agency (EMA). The United States, for its part, has not yet authorized the AstraZeneca formula because clinical studies there are ongoing.

The EMA continues to say the benefits of the AstraZeneca vaccine “outweigh the risks.” Below is their latest communication on the subject. We have bolded key information.

****

EMA’s safety committee (PRAC) is meeting today, Wednesday 31 March, in the context of its ongoing review of very rare cases of unusual blood clots associated with low numbers of platelets, in people vaccinated with AstraZeneca’s COVID-19 vaccine (now called Vaxzevria).

EMA convened an ad hoc expert group meeting on Monday 29 March to provide further input into the ongoing assessment. Independent external experts with a range of medical specialities, including haematologists, neurologists and epidemiologists, discussed specific aspects such as possible mechanisms, whether underlying risk factors could be identified and what additional data are needed to further characterise the observed events and the potential risk. The outcome of this meeting will be discussed by the PRAC and feed into its ongoing evaluation.

At present the review has not identified any specific risk factors, such as age, gender or a previous medical history of clotting disorders, for these very rare events. A causal link with the vaccine is not proven, but is possible and further analysis is continuing.

As communicated on 18 March, EMA is of the view that the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalisation and death, outweigh the risks of side effects.

More information and advice for healthcare professionals and the public is available in the vaccine’s product information and the associated direct healthcare professional communication. Vaccinated people should be aware of the remote possibility of these very rare types of blood clots occurring. If they have symptoms suggestive of clotting problems as described in the product information, they should seek immediate medical attention and inform healthcare professionals of their recent vaccination.

EMA continues to work with the national authorities in the EU Member States to ensure that suspected cases of unusual blood clots are reported; these cases are being analysed in PRAC’s ongoing assessment.

Based on all the currently available data, PRAC is expected to issue an updated recommendation during its April plenary meeting (6–9 April).

The report describing the PRAC’s preliminary assessment of the reported cases of blood clots and conclusionsis available.

More about the procedure

The review of cases of very rare cases of unusual blood clots associated with low blood platelets (thrombocytopenia) is being carried out in the context of a safety signal, under an accelerated timetable. A safety signal is information on a new or incompletely documented adverse event that is potentially caused by a medicine such as a vaccine and that warrants further investigation.

The review is being carried out by EMA’s Pharmacovigilance Risk Assessment Committee (PRAC), the Committee responsible for the evaluation of safety issues for human medicines. Once the review is completed, PRAC will make any recommendations necessary to minimise risks and protect patients’ health. The PRAC recommendations will then be sent to the Committee for Medicinal Products for Human Use (CHMP), responsible for questions concerning medicines for human use, which will rapidly adopt the Agency’s opinion.

EMA provides scientific recommendations underpinning the safe and effective use of COVID-19 vaccines.

EMA’s recommendations are the foundation upon which individual EU Member States will design and implement their own national vaccination campaigns. These may differ from country to country depending on their national needs and circumstances, such as infection rates, priority populations, vaccine availability and hospitalisation rates.

Trending Now

Microsoft Global Outage Disrupts Outlook, Teams and Health Services Worldwide

Microsoft’s global outage ran into a second day Friday. Outlook email is still failing for many users, and parts of Teams, Copilot and other...

US Airline Seats to Costa Rica Fall 14% as Fares Climb

Scheduled US airline seats to Costa Rica are projected to fall 14% through March, with San José down 20%, Liberia down 3% and fares up as much as 45%.

Guided Hikes in Costa Rica Would Need ICT Licenses and Insurance Under New Bill

Companies that sell or lead guided hikes in Costa Rica would need a license from the Costa Rican Tourism Institute (ICT) and insurance covering...

Shakira Returns to Costa Rica in 2027 After More Than 15 Years

Shakira plans a January 31, 2027 show at Costa Rica's National Stadium, her first here since 2011.

5 Costa Rica Parks With Closed Trails or New Rules This High Season

High season is starting, and several of Costa Rica's best-known national parks have a trail, an entrance or a whole sector closed. Others are...

Costa Rica Moves to Demolish Narco Airstrips Without a Conviction

A Costa Rica bill would let authorities destroy clandestine airstrips without a final ruling and freeze land linked to them. It now heads to a floor vote.

Costa Rica President Says Jailed Gang Members Ordered Her Killing

President Laura Fernández said Monday that prison intelligence reports show gang members behind bars have ordered her assassination.

Prosecutors Say They Found Signs of Abuse at Costa Rica’s New Megaprison

Costa Rica's attorney general says prosecutors found signs of possible torture at the CACCO megaprison. The Justice Ministry called the visit a show.

Costa Rica Free Zones Barely Grew and Jobs Disappeared

Production in Costa Rica's free zones, the export parks that host most of the country's multinational employers, grew just 0.6% year-on-year in September, according...
Loading…

Latest News from Costa Rica

Costa Rica Coffee Maker Chorreador
Costa Rica Car Rentals
Costa Rica Travel Insurance
Costa Rica Travel